RaySearch Laboratories Q1: Demonstrating a strong profitability outlook - Redeye
Bildkälla: Stockfoto

RaySearch Laboratories Q1: Demonstrating a strong profitability outlook - Redeye

Redeye returns with a more in-depth take on the Q1 report. While sales and EBIT positively surprised, we leave our fair value range untouched. We repeat that the company’s +25% EBIT margin for 2026e is highly achievable and consider it conservative.

Redeye returns with a more in-depth take on the Q1 report. While sales and EBIT positively surprised, we leave our fair value range untouched. We repeat that the company’s +25% EBIT margin for 2026e is highly achievable and consider it conservative.
Börsvärldens nyhetsbrev